This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

John K. Watters, PhD; Michelle J. Estilo, MPH; George L. Clark; Jennifer Lorvick

JAMA. 1994;271(2):115-120.

Abstract
Objective.
—To evaluate an all-volunteer syringe exchange program in San Francisco, Calif.

Data Sources.
—Syringe exchange program records and 11 semiannual surveys administered during a 5.5-year period, using standard questionnaires. Interviews (N=5644) were conducted with injection drug users recruited in two 21-day drug detoxification clinics and three street settings.

Main Outcome Measures.
—Use of the syringe exchange program and self-reported data regarding sources of syringes, frequency of injection, initiation into drug injection, and frequency of syringe sharing.

Results.
—In spring 1992, 45% reported "usually" obtaining injection equipment from the syringe exchange, and 61% reported using the program within the past year. During the period from December 1986 through June 1992, the median reported frequency of injection declined from 1.9 injections per day to 0.7 injection per day, the mean age increased from 36 to 42 years, and the percentage of new initiates into injection drug use decreased from 3% to 1%. In logistic regression analysis (of fall 1991 through spring 1992 interviews; n=752), we found six independent factors associated with syringe sharing. Protective from syringe sharing were use of the syringe exchange program, having received human immunodeficiency virus (HIV) testing and counseling, condom use, older age, and African-American race. Injection of cocaine was a predictor for syringe sharing. The strength of association between use of the syringe exchange program and not sharing syringes was greatest in injection drug users younger than the median age of 40 years.

Conclusions.
—The syringe exchange program was rapidly adopted by injection drug users. Health interventions associated with not sharing needles included use of the syringe exchange program and voluntary, confidential HIV testing and counseling. Our data did not support the hypothesis that a syringe exchange program would stimulate increased drug abuse in terms of frequency of injection or recruitment of new and/or younger users.

(JAMA. 1994;271:115-120)

Author Affiliations
From the Urban Health Study, Institute for Health Policy Studies (Dr Watters, Ms Estilo, and Ms Lorvick) and the Department of Family and Community Medicine (Dr Watters), School of Medicine, University of California, San Francisco, and the Prevention Point Research Group, San Francisco, Calif (Mr Clark). Presented in part at the 7th International Conference on AIDS, Florence Italy, June 20, 1991.

Footnotes
Reprint requests to the School of Medicine, Box 1304, University of California, San Francisco, CA 94143-1304 (Dr Watters).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of an Intensive Street-Level Police Intervention on Syringe Exchange Program Use in Philadelphia, Pa
Davis et al.
AJPH 2005;95:233-236.
ABSTRACT | FULL TEXT  

Human Immunodeficiency Virus Type 1 Superinfection Was Not Detected following 215 Years of Injection Drug User Exposure
Tsui et al.
J. Virol. 2004;78:94-103.
ABSTRACT | FULL TEXT  

Trends in Human Immunodeficiency Virus Seroincidence among Street-Recruited Injection Drug Users in San Francisco, 1987-1998
Kral et al.
Am J Epidemiol 2003;157:915-922.
ABSTRACT | FULL TEXT  

Validity of Self-reported Needle Exchange Attendance among Injection Drug Users: Implications for Program Evaluation
Safaeian et al.
Am J Epidemiol 2002;155:169-175.
ABSTRACT | FULL TEXT  

Predictors and Prevention of Nonfatal Overdose Among Street-Recruited Injection Heroin Users in the San Francisco Bay Area, 1998-1999
Seal et al.
AJPH 2001;91:1842-1846.
ABSTRACT | FULL TEXT  

Cost-effectiveness of Harm Reduction in Preventing Hepatitis C among Injection Drug Users
Pollack
Med Decis Making 2001;21:357-367.
ABSTRACT  

Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?
Wood et al.
CMAJ 2001;165:405-410.
ABSTRACT | FULL TEXT  

Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?
Edlin et al.
NEJM 2001;345:211-214.
FULL TEXT  

Sex Differences in Risk Factors for HIV Seroconversion Among Injection Drug Users: A 10-Year Perspective
Strathdee et al.
Arch Intern Med 2001;161:1281-1288.
ABSTRACT | FULL TEXT  

Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions
van Ameijden and Coutinho
J. Epidemiol. Community Health 2001;55:356-363.
ABSTRACT | FULL TEXT  

AIDS and Stigma
HEREK
American Behavioral Scientist 1999;42:1106-1116.
ABSTRACT  

Primary Care as Harm Reduction for Injection Drug Users
Gunn et al.
JAMA 1998;280:1191-1195.
FULL TEXT  

Prevention of HIV/AIDS and Other Blood-Borne Diseases Among Injection Drug Users: A National Survey on the Regulation of Syringes and Needles
Gostin et al.
JAMA 1997;277:53-62.
ABSTRACT  

Temporal Trends of Incident Human Immunodeficiency Virus Infection in a Cohort of Injecting Drug Users in Baltimore, Md
Nelson et al.
Arch Intern Med 1995;155:1305-1311.
ABSTRACT  

HIV Seroprevalence in Injection Drug Users
Watters et al.
JAMA 1995;273:1178-1178.
ABSTRACT  

Regulating Syringe Exchange Programs: A Cautionary Note
Jarlais et al.
JAMA 1994;272:431-432.
ABSTRACT  

Syringe and Needle Exchange to Prevent HIV Infection
Fernando
JAMA 1994;271:1825-1825.
ABSTRACT  

Syringe and Needle Exchange to Prevent HIV Infection
Heimer and Lopes
JAMA 1994;271:1825-1826.
ABSTRACT  

Addiction Medicine
Franklin
JAMA 1994;271:1650-1651.
ABSTRACT  

REDUCING HIV RISK IN DRUG INJECTORS: A PROGRESS REPORT
JWatch General 1994;1994:1-1.
FULL TEXT  

'Into Whatever Houses I Enter' HIV and Injecting Drug Use
Wartenberg
JAMA 1994;271:151-152.
ABSTRACT